Merck (MRK) Said Planning to Join Bidding for Stada - Source
Tweet Send to a Friend
U.S. drug giant Merck (NYSE: MRK) could enter the fray with a bid for contested Germany-based generics company Stada Arzneimittel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE